BMAL1 and glioblastoma: Notably, a study performed by Dong et al. found that downregulation of CLOCK/BMAL1 negatively affected proliferation and cell cycle progression in Glioblastoma Stem Cells (GSCs) but not in Neural Stem Cells (NSCs)16.